Eurofins Biomnis
Eurofins Biomnis is a Lyon-based clinical diagnostic laboratory subsidiary of Eurofins Scientific SE that provides specialized medical biology testing—including LC-MS/MS toxicology, PCR, and NGS assays—to clinical laboratories, healthcare providers, and public health authorities across France and Europe.
- Company typePrivate
- Founded1897
- HeadquartersLyon, France
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Eurofins Biomnis does
Eurofins Biomnis is a clinical diagnostic laboratory headquartered in Lyon, France, operating as a subsidiary of Eurofins Scientific SE, a publicly traded testing conglomerate listed on Euronext Paris. Founded in 1897, the company provides specialized medical biology services to clinical laboratories, healthcare providers, and public health authorities across France, Spain, Germany, and the United States through the broader Eurofins laboratory network. Its core technology portfolio centers on liquid chromatography tandem mass spectrometry (LC-MS/MS), quantitative real-time PCR, and next-generation sequencing (NGS) assays, with ISO 15189-accredited methods covering applications such as cereulide toxin detection in stool samples and pathogen surveillance during outbreak situations.
The company's product and service menu is concentrated in high-complexity, niche diagnostic testing rather than high-volume routine work. Revenue is generated through professional services—fee-for-service clinical laboratory testing billed to healthcare providers, clinical laboratories, and governmental public health organizations—under quote-based pricing determined by test complexity, volume, and client agreements. The go-to-market motion is sales-led and B2B, distributing services through direct laboratory relationships and, more recently, through the Eurofins Biomnis Connect digital portal for ordering and results delivery. Customer segments are horizontally distributed across clinical labs, healthcare providers, and public health authorities, with the company serving as a specialized reference laboratory within the Eurofins group's diversified diagnostic infrastructure.
Eurofins Biomnis firmographics
Firmographics- Name
- Eurofins Biomnis
- Website
- https://eurofins-biomnis.com
- Company type
- Private
- Founded year
- 1897
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Eurofins Biomnis is a Lyon-based clinical diagnostic laboratory subsidiary of Eurofins Scientific SE that provides specialized medical biology testing—including LC-MS/MS toxicology, PCR, and NGS assays—to clinical laboratories, healthcare providers, and public health authorities across France and Europe.
- Ownership category
- akta.pro rank
Eurofins Biomnis industry classification
Industry- Product category
- Clinical Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Proteomics & Biomarker Analytical Testing (HLAGADAG)
- akta.pro secondary industries
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)
Keywords
Where Eurofins Biomnis is headquartered
LocationHeadquarters
- HQ city
- Lyon
- HQ country
- France
- HQ region
- Europe
Markets served
Eurofins Biomnis business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Laboratory Testing Services: Eurofins Biomnis generates revenue through providing clinical diagnostic testing services to healthcare providers, laboratories, and health authorities. The company offers specialized testing methods including LC-MS/MS analysis with turnaround times compatible with routine medical biology practice.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Eurofins Biomnis product offering
Product offeringCore offering
Eurofins Biomnis provides specialized clinical diagnostic laboratory testing services to healthcare providers, clinical laboratories, and public health authorities. Its portfolio centers on mass spectrometry-based testing (LC-MS/MS), molecular diagnostics including real-time PCR, and next-generation sequencing assays used for toxin detection, pathogen surveillance, and routine medical biology analysis. Services are delivered through a network of European laboratories under the Eurofins Scientific SE corporate umbrella.
Product overview
Eurofins Biomnis is a clinical diagnostic laboratory division of Eurofins Scientific offering specialized clinical laboratory testing services. Their portfolio includes liquid chromatography tandem mass spectrometry (LC-MS/MS) testing methods such as the cereulide toxin detection method, as well as molecular and serological diagnostic solutions. The company operates through a network of European laboratories in France and other locations, providing testing capabilities to support health authorities and routine medical biology practice.
Differentiator
Problem solved
Functional benefit
Products and services
- LC-MS/MS Cereulide Toxin Detection Method
Quantifiable outcome
- Turnaround times compatible with routine medical biology practice
Companies that use Eurofins Biomnis
Customer profileSegments3 records
Ideal customer profiles3 records
Eurofins Biomnis technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Eurofins Biomnis partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights4 records
Eurofins Biomnis competitors and assessment
Company assessmentBroad incumbents
- Quest Diagnostics: Quest Diagnostics is one of the largest clinical laboratory networks globally, offering routine and advanced diagnostic testing. It is a broad incumbent that overlaps with Eurofins Biomnis' specialty testing franchise at much larger scale.
- Laboratory Corporation of America (Labcorp): Labcorp is a major US-headquartered clinical laboratory operator with global esoteric testing capabilities. As a broad incumbent it competes with Eurofins Biomnis' specialty and reference lab services, particularly in biomarker and advanced diagnostics.
- Sonic Healthcare: Sonic Healthcare is a global medical diagnostics company operating laboratory networks across Australia, Europe and the US. It is a broad incumbent that overlaps with Eurofins Biomnis in routine and specialty clinical laboratory services.
Direct peers
- ARUP Laboratories: ARUP Laboratories is a US-based clinical reference laboratory specializing in esoteric and complex diagnostic testing, including mass spectrometry and molecular diagnostics. It is closely comparable to Eurofins Biomnis' specialty clinical testing model.
- Unilabs: Unilabs is a major European clinical laboratory group providing diagnostic testing services to healthcare providers across multiple countries. It is a direct competitor to Eurofins Biomnis in the medical biology and specialty testing market.
- Mayo Clinic Laboratories: Mayo Clinic Laboratories is the reference laboratory of Mayo Clinic offering highly specialized clinical and esoteric testing worldwide. It is directly comparable to Eurofins Biomnis in providing advanced diagnostic assays to healthcare providers.
- Synlab: Synlab is one of Europe's largest medical diagnostic services providers, operating clinical laboratories across Western Europe. It is directly comparable to Eurofins Biomnis in providing routine and specialty clinical testing to hospitals, physicians and public health bodies.
- Cerba HealthCare: Cerba HealthCare operates a network of specialty and routine clinical laboratories across Europe with strong positions in France. It directly competes with Eurofins Biomnis in clinical diagnostic testing, including esoteric and biomarker assays.
- Laboratoire Cerba: Laboratoire Cerba is a French reference laboratory specializing in specialized clinical testing. It competes directly with Eurofins Biomnis in esoteric diagnostic testing serving clinicians and hospitals in France and internationally.
Regional players
- Inovie: Inovie is a French regional clinical laboratory network providing medical biology testing across France. It competes with Eurofins Biomnis in the French clinical diagnostics market, though with a less internationally focused footprint.
Market position
Strengths1 record
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Eurofins Biomnis social profiles
Digital presenceEurofins Biomnis compliance and trust
Trust signalCompliance1 record
Eurofins Biomnis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eurofins Biomnis leadership team
Management profileNumber of profiles
Profiles1 record
Eurofins Biomnis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eurofins Biomnis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eurofins Biomnis
What does Eurofins Biomnis do?
Eurofins Biomnis provides specialized clinical diagnostic laboratory testing services to healthcare providers, clinical laboratories, and public health authorities. Its portfolio centers on mass spectrometry-based testing (LC-MS/MS), molecular diagnostics including real-time PCR, and next-generation sequencing assays used for toxin detection, pathogen surveillance, and routine medical biology analysis. Services are delivered through a network of European laboratories under the Eurofins Scientific SE corporate umbrella.
Is Eurofins Biomnis a public or private company?
Eurofins Biomnis is a private company. It is classified as corporate owned and is currently operating.
When was Eurofins Biomnis founded?
Eurofins Biomnis was founded in 1897. It employs 101 to 250 people.
Where is Eurofins Biomnis based?
Eurofins Biomnis is headquartered in Lyon, France, in the Europe region.
How does Eurofins Biomnis make money?
One revenue line is on record: clinical Laboratory Testing Services.
Who are Eurofins Biomnis's main competitors?
Broad incumbents on record are Quest Diagnostics, Laboratory Corporation of America (Labcorp) and Sonic Healthcare. Direct peers are ARUP Laboratories, Unilabs, Mayo Clinic Laboratories, Synlab, Cerba HealthCare and Laboratoire Cerba. Inovie is listed as a regional player.
Does Eurofins Biomnis have an API?
No public API is recorded for Eurofins Biomnis.
What industry is Eurofins Biomnis in?
Eurofins Biomnis's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAGADAG, Proteomics & Biomarker Analytical Testing, with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 621511 and its SIC code is 8071.